Brief: ChemoTech: Outcome Of Directed Issue
May 19 (Reuters) - Scandinavian ChemoTech AB CMOTECb.ST: CHEMOTECH ANNOUNCES OUTCOME OF THE DIRECTED ISSUE ISSUES 761,191 NEW CLASS A SHARES TOTALING ABOUT SEK 2.55 MILLION SUBSCRIPTION PRICE SET AT SEK 3.35 PER CLASS A SHARE, 10% DISCOUNT TO VWAP Source text: ID:nWkr7HrBVW Further company coverage: [CMOTECb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Scandinavian ChemoTech AB
See all newsBrief: Chemotech Enters Strategic Partnership With University Of Copenhagen's Veterinary Hospitals
Brief: Scandinavian Chemotech Secures SEK 6 Mln Growth Loan
Brief: ChemoTech: Outcome Of Directed Issue
Sweden's ChemoTech Q1 net sales rise, loss narrows on US operation improvement
Brief: ChemoTech Q1 Sales SEK 2.798 Million